Cite
HARVARD Citation
Richter, A. et al. (n.d.). SAT0674 Early treatment response to conventional dmard therapy in rheumatoid arthritis is a better predictor of low disease activity or treatment escalation at 12 and 24 months than autoantibodies or erosions. Annals of the rheumatic diseases. pp. 1029-1030. [Online].